Ridaforolimus Eluting Stent System


A pioneer in cardiovascular intervention for 25 years, Medinol raises the bar once again with the introduction of the EluNIR elastomeric Drug-Eluting Stent — a category-of-one innovation purposefully designed to meet the unique demands of the the ever-changing vascular environment.

Dotter has launched this innovative device in the Korean market by acquiring the rights to sell the product from Medinol.

Stay updated

& Updates

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque in tempor nulla. Etiam nec vulputate odionec vitae sem ornare, hedrerit tortor all eget, vestibulum libero auisque in exllert ante bladit mollis. Sndisse imperdiet erat lorem, at tempor nisi cursus seder.

[소부장 스타트업] 도터 “글로벌 의료기업 능가하는 차세대 생분해성 스텐트, 우리 손으로”

심장 급사의 원인이 되는 심혈관 협착증의 예방 및 치료를 위해 스텐트(Stent)로 혈관을 넓히는 시술은 이미 일반화되었다. 하지만 기존의 금속 재질 스텐트가 체내에 장기간 자리하면서 발생할 수 있는 부작용도 지적되고 있다. 도터는 이러한 우려를 해소할 수 있는 생분해성 스텐트(Bioresorbable Stent, BRS) 솔루션을 선보였다.

Korea Health Industry Development Institute held ‘The 5th K-BIC Star Day’

The Korea Health Industry Development Institute (President Deok-cheol Kwon), along with the domestic venture investment platform KDB NextRound, held the ‘2019 5th K-BIC STAR DAY’ (hereafter K-BIC Star Day) held at the IR Center of the KDB in Yeouido on the 1st. It was announced on the 2nd that it was successfully held.


Get In touch


Inquiries about products or suggestions for partnerships
are always welcome

phone  +
Fax +